EATG » News

Join the EATG at the 2018 HIV Drug Therapy Congress in Glasgow

The European AIDS Treatment Group is present at the 2018 HIV Drug Therapy Congress in Glasgow, from the 28th to the 31st of October. As with the previous versions of…

Call for applications: Continuous Patient Education (CoPE) Special call about Living & Ageing with HIV (Quality of Life)

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information on how to apply for this grant. The submission deadline…

HIV Travel: The Global Database on HIV-specific Travel and Residence restrictions is updated

The Global Database on HIV-specific Travel & Residence Restrictions, a useful online tool regarding the cross-border mobility of people living with HIV/AIDS, was recently updated. This is a joint collaboration…

M-Care 2018: Sharing the outcomes of the migrant advocates training programme

Today, Africa Advocacy Foundation (AAF) and the European AIDS Treatment Group (EATG) are launching the M-Care 2018 training programme report. Together with the report we are also launching a set of video…

The EU Civil Society Forum on HIV/AIDS, TB and viral hepatitis reacts to the relevant Commission Staff Working Document

GASTEIN - On 4 October -on the occasion of the European Health Forum discussion on Reaching the SDG targets on Health by 2030 - Actions needed to end AIDS & TB…

#JusticeForZak: sign the petition, join the campaign

On Friday 21 September, Zak Kostopoulos, died as a consequence of brutal beatings in Athens Greece. We call all relevant Greek authorities for a swift, thorough, independent and impartial investigation into…

We call on the authorities to ensure that justice for Zak Kostopoulos is done

On Friday 21 September, Zak Kostopoulos, died as a consequence of brutal beatings in Athens Greece. Zak was an HIV+, sex positive, queer, human rights’ activist and defender, also raising…

EATG General Assembly 2018 (Vilnius, 27-30 September)

The European AIDS Treatment Group is holding its annual General Assembly in Vilnius, Lithuania over the next four days. More than 75 members and the staff of EATG are gathering…

The Value of Health: Improving Outcomes final report was launched

Today, the The Value of Health: Improving Outcomes multi-stakeholder initiative launched its final report at the European Parliament. European AIDS Treatment Group's chair, Nikos Dedes, highlighted the critical importance of…

The European AIDS Treatment Group is looking for a Financial Assistant

Type of contract: Half-time, temporary position with possibility for extension Location: Brussels, Belgium Reporting to: Executive Director Start date: As soon as possible The European AIDS Treatment Group is looking…

The European AIDS Treatment Group is looking for an Executive Director

Type of contract: Full-time, permanent contract Location: Brussels, Belgium Reporting to: Board of Directors Start date: As soon as possible in the range of October-December 2018 The European AIDS Treatment…

2nd Hep-C Community Summit: We are more than just patients

The European AIDS Treatment Group participates in the 2nd Hep-C Community Summit that takes place on the 18th of September in Lisbon. Organised by Correlation European Harm Reduction Network, the summit will…

Webinar: Patient Engagement on Medicines Research & Development

Join us for a webinar about patient engagement in the process of research and development of medicines on Thursday, September 6 from 18:00 to 19:15 CET.   Four European patient…

Open letter: UN General Assembly High Level Meeting on the fight against Tuberculosis

Few weeks before the UN General Assembly High Level Meeting on the fight against Tuberculosis, the EATG issues an open letter: 'As negotiations on the final declaration are now being…

ESTICOM: First from a series of community reports from EMIS 2017 is now online

A week ago the EATG co-chaired the satellite symposium "European surveys and trainings to improve MSM community health (ESTICOM)" at the 22nd International AIDS conference.  During this session we had…

The EATG welcomes the European Court of Justice decision to invalidate the patent extension of Truvada

Amsterdam, 26 July 2018   The European AIDS Treatment Group welcomes the landmark decision of the European Court of Justice confirming the invalidity of the patent extension (Supplementary Protection Certificate)…

EATG at the 22nd International AIDS conference: Catch up with the evidence and give our communities the services we need

Amsterdam, 23 July 2018   As an organisation led by people living with HIV/AIDS across Europe and Central Asia, working together with the several affected communities in the last 25…

AIDS 2018: Addressing research gaps identified by women living with HIV in Europe and Central Asia

We are pleased to invite you to join a side-meeting at the AIDS 2018 conference that will bring together community, clinicians and researchers to discuss research gaps related to women…

AIDS 2018: The programme and the presentations of the European Civil Society Forum booth in the Global Village

The EATG and AIDS Action Europe are co-hosting the European Civil Society Forum (booth 618) at the Global Village of the 22nd International AIDS Conference in Amsterdam. Organisations and activists…

Ageing with HIV conference outcomes: read watch and register to discuss

The EATG organised a conference titled ‘New challenges and unmet needs of people living and ageing with HIV/AIDS aged 18-50, Quality of Life and Preventive Healthcare’ from 3 to 6…

First evidence of HIV reservoirs in macrophages

Basic scientists in France have recently discovered that macrophages located in urethral tissue can contribute to cellular HIV reservoirs, and that the quantity of these specific immune cells is surprisingly…

DAA treatment reduces the risk of death and liver cancer in France

Treatment with direct-acting antivirals reduced the risk of death, liver cancer and death from liver-related causes in French people with hepatitis C, according to results of one of the largest…

Informal PrEP: an emerging need for nomenclature

Different expressions are used to describe the process of informal access to antiretroviral drugs (eg, via the Internet or acquaintances) for HIV pre-exposure prophylaxis (PrEP): “informal use”, “informal PrEP”, “off-label…

HIV crisis in the Philippines: urgent actions needed

The Philippines is facing the fastest growing HIV epidemic in the western Pacific, with a 174% increase in HIV incidence between 2010 and 2017. There were 1047 new cases in…

Emtricitabine in dried blood spots predicts HIV viral suppression

The level of emtricitabine triphosphate (FTC-TP), an anabolite of emtricitabine, in dried blood spots (DBS) predicts HIV viral suppression and reflects short-term adherence to therapy, researchers report. "We know that…

Tracking HIV’s ever-evolving genome in effort to prioritize public health resources

In one example, researchers uncovered an unexpected pattern of HIV infection among transgender women and cisgender men in Los Angeles County Every county in the United States tracks HIV cases,…

Grazoprevir plus elbasvir effectively treats acute hepatitis C infection

Treatment of hepatitis C virus (HCV) with grazoprevir plus elbasvir is effective in the acute phase of infection and therefore should be used in patients at high risk for HCV…

‘Gag rule’ threatens to restrict women’s access to a highly effective HIV therapy

The Trump administration’s disregard for women’s rights is reflected in its attempt to remove the Affordable Care Act’s mandate that insurers cover birth control and its expansion of the “global…

IMPAACT study on HIV and TB medications taken during pregnancy to begin new phase in 2019

An ongoing study funded by the National Institutes of Health (NIH) is investigating how women process medications for HIV and tuberculosis (TB) during pregnancy in an effort to inform treatment…

New discovery could lead to ways to protect HIV patients from deadly TB

Director of the Southwest National Primate Research Center Professor Deepak Kaushal, Ph.D. says research he collaborated on is pinpointing a possible new avenue of protection for HIV/AIDS patients. The study, published this month in…

Smoking, cholesterol, blood pressure are more important causes of disease than HIV in people living with HIV

Preventing smoking, lowering cholesterol, controlling blood pressure and curing hepatitis C would greatly reduce the burden of heart attacks, non-AIDS cancers and end-stage liver disease and kidney disease in people…

Tenofovir alafenamide linked to Fanconi syndrome

Tenofovir alafenamide (TAF) may cause Fanconi syndrome in patients with HIV, according to a case study published in the Annals of Internal Medicine. Fanconi syndrome has already been established as a…

Correlation between HIV, rectal gonorrhea could help PrEP trial designs

Study findings showed a correlation between the incidence of rectal gonorrhea and HIV infection among men who have sex with men who are not using pre-exposure prophylaxis, or PrEP, for…

Study recommends reconsidering hepatitis A vaccination protocol to prevent a vaccine-resistant virus

Researchers of the University of Barcelona (UB) have used massive sequencing techniques with samples from patients to determine the evolution of the hepatitis A virus. The results, published in the…

Low testosterone persists after HCV clearance

Low levels of free testosterone are common among men with chronic hepatitis C infection following SVR and persist after HCV clearance, according to findings from a prospective, longitudinal cohort study.…

ALT flares in HBV low, linked to seroconversion in untreated patients

Among patients with chronic hepatitis B, the cumulative incidence of severe alanine aminotransferase flares was low and correlated with decreased HBV DNA levels and loss of HBV e-antigen, according to…

TB activists for first time challenge TB drug patent in India

TB activists for first time challenge TB drug patent in India, in bid to prevent Johnson & Johnson from extending monopoly. Mumbai/Cape Town, 6 Feb 2019 — Médecins Sans Frontières…

Trump State of the Union plan to end new HIV infections by 2030 only realistic with sweeping policy changes

In response to reports that President Trump will use the State of the Union address to announce a plan to end new HIV infections in the U.S. by 2030 while…

Tackling HIV and hepatitis C in Europe: towards minimum standards

Despite the huge disparities in care that were highlighted, last week's Standard of Care for HIV and Coinfections in Europe meeting in Bucharest featured discussions that could form the basis of…

ECDC: HIV infection and AIDS – Annual epidemiological report for 2017

The European Centre for Disease Prevention and Control (ECDC) released HIV infection and AIDS - Annual epidemiological report for 2017. The report can be downloaded here.